UBS Downgrades ABM Indus to Neutral, Lowers Price Target to $51

Benzinga · 12/18/2025 13:48
UBS analyst Joshua Chan downgrades ABM Indus (NYSE:ABM) from Buy to Neutral and lowers the price target from $55 to $51.